前列腺癌术后放疗使用与就医距离的关联
该研究基于美国国家癌症数据库,纳入2004至2015年接受 upfront 手术且为pT2期、切缘阴性的170379例前列腺癌患者,分析术后放疗(PORT)使用率与治疗机构距离的关系。结果显示距离越远PORT使用率越低,提示放疗设施的地理可及性可能影响治疗决策。
要点
- pT2切缘阴性前列腺癌术后PORT总体使用率低(<5英里者1.37%)。
- 距离≥10英里者PORT使用率显著低于<5英里者(10-20英里AOR 0.80,≥20英里AOR 0.47)。
- 研究提示地理可及性可能影响持续可检测PSA患者的PORT决策。
核心结论
- 对于无不良病理特征的局限期前列腺癌手术患者,距治疗机构越远,接受PORT的比例越低。
研究设计与样本
- 基于美国国家癌症数据库的回顾性队列研究,纳入2004至2015年接受 upfront 手术且为pT2期、切缘阴性的170379例前列腺癌患者。
- 采用多因素logistic回归,以是否接受PORT为主要因变量,以距治疗设施距离(<5、5-10、10-20、≥20英里)为主要自变量,计算调整比值比(AOR)及95%置信区间(CI)。
临床怎么用
- 临床决策时应关注患者距放疗设施的距离,避免因地理可及性差异影响持续可检测PSA患者接受PORT的机会。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: After radical prostatectomy, men with adverse pathologic features or a persistent postoperative detectable prostate-specific antigen (PSA) are candidates for postoperative radiation therapy (PORT). Previous data have suggested disparities in receipt of adjuvant radiation therapy for adverse pathologic features according to travel distance. Among patients without adverse pathologic features (pT2 disease and negative margins), the main indication for PORT is a persistent postoperative detectable PSA. However, it remains unknown whether the rate of receipt of PORT in this cohort of men with persistently detectable PSA is related to travel distance from the treating facility. METHODS AND MATERIALS: Using the National Cancer Database, we identified 170,379 men with prostate cancer diagnosed from 2004 to 2015 managed with upfront surgery who were found to have pT2 disease with negative surgical margins. Multivariable logistic regression defined adjusted odds ratios (AORs) with 95% confidence intervals (CIs) of receiving PORT as the primary dependent variable and distance (<5, 5-10, 10-20, ≥20 miles from the treatment facility) as the primary independent variable. RESULTS: Within our cohort, progressively farther distance from the treatment facility was associated with lower rates of PORT. In patients living <5 miles, 5 to 10 miles, 10 to 20 miles, and >20 miles from the treating facility, rates of PORT of were 1.37% (referent), 1.16% (AOR, 0.90; 95% CI, 0.79-1.04; P = .158), 0.98% (AOR, 0.80; 95% CI, 0.70-0.93; P = .003), and 0.64% (AOR, 0.47; 95% CI, 0.41-0.54; P < .001), respectively. CONCLUSIONS: For men with localized prostate cancer without adverse pathologic features managed with surgery, increasing distance from treatment facility was associated with lower receipt of PORT. Given that the rate of a persistent postoperative detectable PSA is unlikely to depend on the distance to the treatment facility, these findings raise the possibility that the geographic availability of radiation treatment facilities influences the decision to undergo PORT for patients with persistent postoperative detectable PSA.
引用
- Arega MA, Yang DD, Royce TJ, et al. Association Between Travel Distance and Use of Postoperative Radiation Therapy Among Men With Organ-Confined Prostate Cancer: Does Geography Influence Treatment Decisions? Pract Radiat Oncol. 2021. PMID: 33340712. doi:10.1016/j.prro.2020.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。